ACT Losartan / HCT (2017-09-01)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: Healthcare Professionals, General Public, Hospitals
Department: Health Canada
Hazard classification: Type III
| Lot or serial number | Companies | Brand name | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| K50626 | - Recalling Firm
- Teva Canada Limited
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
- Marketing Authorization Holder
- Teva Canada Limited
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
| ACT Losartan / HCT | Tablet | 02388278 | 12.5mg - Hydrochlorothiazide |
Affected products
ACT Losartan / HCT
Out of specification for Hydrochlorothiazide assay in affected lot
wholesalers and retailers, including pharmacies within Canada